Efficacy and safety of plerixafor in pediatric cancer patients undergoing peripheral blood stem cell harvest for autologous hematopoietic stem cell transplant.

导出 LinkOut

翻译打印收藏纠错

作者： Aditya Kumar,Gupta ^[1] ; Jagdish Prasad,Meena ^[1] ; Hem Chandra,Pandey ^[2] ; Poonam,Coshic ^[2] ; Rachna,Seth ^[1]

作者单位： Division of Pediatric Oncology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India. ^[1] Department of Transfusion Medicine, All India Institute of Medical Sciences, New Delhi, India. ^[2]

关键词 autologous transplant pediatrics plerixafor

DOI 10.31547/bct-2022-022

PMID 38146356

发布时间 2023-12-27

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Blood cell therapy

2023年6卷3期

72-76页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Efficacy and safety of plerixafor in pediatric cancer patients undergoing peripheral blood stem cell harvest for autologous hematopoietic stem cell transplant.

Blood cell therapy

相似文献

Blood cell therapy

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Efficacy and safety of plerixafor in pediatric cancer patients undergoing peripheral blood stem cell harvest for autologous hematopoietic stem cell transplant.

Blood cell therapy

相似文献

Blood cell therapy

相关期刊

检索历史清除